Murine models of inflammatory bowel disease (IBD): challenges of modeling human disease (Q26863622)

inflammatory bowel diseases

main subject

0 references

0 references

1 reference

J. DeVoss

27

0 references

L. Diehl

series ordinal

2

1 reference

language of work or name

1 reference

January 2014

1 reference

published in

Toxicologic Pathology

1 reference

volume

42

1 reference

issue

1

1 reference

page(s)

99-110

1 reference

Drug development: Raise standards for preclinical cancer research

cites work

1 reference

https://api.crossref.org/works/10.1177/0192623313509729

Diversity of the human intestinal microbial flora

20 April 2017

1 reference

https://api.crossref.org/works/10.1177/0192623313509729

Induction of intestinal Th17 cells by segmented filamentous bacteria

20 April 2017

1 reference

https://api.crossref.org/works/10.1177/0192623313509729

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1177/0192623313509729

Believe it or not: how much can we rely on published data on potential drug targets?

20 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Unravelling the pathogenesis of inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis

20 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Inflammatory bowel disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Post-transcriptional regulation of tumour necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Trial watch: Phase II failures: 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Phase III and submission failures: 2007–2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Preclinical models used for immunogenicity prediction of therapeutic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

GWA studies: rewriting the story of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Milk fat globule-EGF factor 8 is a critical protein for healing of dextran sodium sulfate-induced acute colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Challenges of biomarkers in drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

21 January 2018

Indeterminate colitis

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

JAM-A regulates permeability and inflammation in the intestine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Enteropathogenic Escherichia coli and ulcerative colitis in cotton-top tamarins (Saguinus oedipus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Review article: strategies for the management of chronic unremitting ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Challenges in the codevelopment of companion diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Role of the microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Dextran sodium sulphate colitis mouse model: traps and tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

IL-17C regulates the innate immune function of epithelial cells in an autocrine manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

The placebo response rate in irritable bowel syndrome and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Design issues and outcomes in IBD clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Induction of TNBS colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Impact of anti-drug antibodies in preclinical pharmacokinetic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

STW 5 is effective in dextran sulfate sodium-induced colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

MTG16 contributes to colonic epithelial integrity in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

The use of biologic agents in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729

Detecting shared pathogenesis from the shared genetics of immune-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0192623313509729